Draft genome sequence of emerging pathogen Morganella morganii strain PS00513 isolated from a chronic surgical wound
Kira N. Allison, Rayhane Mejlaoui, Katrina G. DeZeeuw, Jonah E. Marek, Edana Cassol, Joerg Overhage

TL;DR
This paper presents the draft genome sequence of a Morganella morganii strain from a chronic wound, highlighting its antibiotic resistance genes.
Contribution
The study provides a new draft genome and resistance gene profile of an emerging pathogen from a clinical wound sample.
Findings
The genome includes a 3.87 Mb chromosome and a 9.6 kb plasmid.
Both genome components contain multiple antibiotic resistance genes.
Abstract
We report the draft genome sequence and antimicrobial resistance gene profile of Morganella morganii strain PS00513. This strain was isolated from a chronic surgical wound infection of an adult male patient. The chromosome is 3.87 Mb long and accompanied by a 9.6 kb plasmid, which both contain multiple antibiotic resistance genes.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSurgical site infection prevention · Antibiotic Resistance in Bacteria · Bacterial Identification and Susceptibility Testing
ANNOUNCEMENT
Chronic wounds are persistent, non-healing wounds often associated with underlying infections and biofilm formation, both of which contribute to delayed wound healing (1). Traditionally, the gram-negative facultative anaerobic gut bacterium, Morganella morganii, is becoming increasingly recognized as an emerging opportunistic pathogen in a variety of different infections, including chronic wounds, where its antibiotic resistance and toxin production are concerning factors (2–4).
M. morganii strain PS00513 was isolated from a culture swab taken from the edge of a surgical chronic wound on the shin of an adult male patient in Ottawa, Canada. The isolate was selected from Cetrimide Agar (Sigma-Aldrich) supplemented with 0.5 mg/L ciprofloxacin after 37°C incubation for 48 h. For whole genome sequencing, cells were grown at 37°C for 18 h at 280 rpm in Luria–Bertani media. DNA was extracted using the PureLink Microbiome DNA Purification Kit (Invitrogen) following the protocol optimized for microbial culture extraction [MAN0014332 Rev.A (10 Sept. 2015)]. The sequencing library was prepared for Oxford Nanopore Technologies (ONT) using Rapid Sequencing Kit V14 (SQK-RAD114, ONT) and sequenced with MinION (Mk1B) and Flongle R10.4.1 (FLO-FLG114) for 24 h. Read quality was assessed with MinKNOW.v.23.04.3 (q score > 9), and basecaller dorado.v.7.3.9 (https://github.com/nanoporetech/dorado) detected and removed adapter/primer sequences concurrently. High-accuracy mode Guppy.v.6.5.7 (https://nanoporetech.com/) generated fastq files for flye.v.2.9.3-b1797 (5) to perform de novo genome assembly (no genome rotation) and overlap detection and trimming. Variant calling, error correction, and polishing were performed with medaka.v.1.11.3 (https://github.com/nanoporetech/medaka) and genome annotation with prokka.v.1.14.5 (6). ResFinder.v.2.4.0 (7, 8) and EPI2ME antimicrobial resistance (AMR) workflow (v2023.04.26-1808834) with input reads aligned against reference sequences in the Comprehensive Antimicrobial Resistance Database (CARD) (9) were used for taxonomic and AMR gene identification. Default parameters and protocols were utilized, unless stated otherwise. Ethical approval for the study was granted by the Carleton University Ethics Committee (118036).
Overall, 130.23 K raw sequencing reads with a mean read length of 7211 kb were used to construct both M. morganii chromosome (3,872,624 bp; 51% G + C) and plasmid (9,635 bp; 63.5% G + C). Genome completeness was 80.01%, with 112× coverage, estimated read N50 of 11.77 Kb, and assembly N50 of 3,872,624 bp, resulting in 3,794 predicted genes. The high G + C content of 51% is characteristic of M. morganii strains (10, 11) often used to distinguish Morganella from other Proteeae species (12). Using ResFinder, antibiotic resistance to five antibiotic classes was identified: aminoglycosides (strB_M28829, aph(3′)-Ia_V00359), beta-lactams (blaDHA-17_KM087850, blaTEM-1B_AY458016), folate pathway antagonists (sul1_U12338, dfrA7_AB161450), tetracyclines (tetC_AJ517790), and amphenicol (catA1_V00622). EPI2ME AMR detection found the same resistance phenotypes in addition to 143 alignments to the CARD protein variant model (93.6% average alignment accuracy) to a point mutation in M. morganii gyrB (13), indicating resistance to fluoroquinolones. The accompanying plasmid contained genes conferring resistance to tetracycline (tet(A)_AJ517790) indicated by ResFinder.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Versey Z, da Cruz Nizer WS, Russell E, Zigic S, De Zeeuw KG, Marek JE, Overhage J, Cassol E. 2021. Biofilm-innate immune interface: contribution to chronic wound formation. Front Immunol 12:648554. doi:10.3389/fimmu.2021.64855433897696 PMC 8062706 · doi ↗ · pubmed ↗
- 2Yang Y, Zhang H, Zhao R, Qiu X, Ye J, Lu W, Li Q, Wu G. 2024. Distribution diversity and expression regulation of class 1 integron promoters in clinical isolates of Morganella morganii. Front Microbiol 15. doi:10.3389/fmicb.2024.1459162 PMC 1152765339493848 · doi ↗ · pubmed ↗
- 3Abedi AS, Mc Elroy JL, Valencia V, Worcester RM, Yu ZJ. 2024. Treatment of Morganella morganii-associated non-healing diabetic foot ulcer with vaporous hyperoxia therapy: a case report. Cureus 16:e 60413. doi:10.7759/cureus.6041338883037 PMC 11179845 · doi ↗ · pubmed ↗
- 4Alsaadi A, Alghamdi AA, Akkielah L, Alanazi M, Alghamdi S, Abanamy H, Aljehani S, Aldibasi OS, Bosaeed M. 2024. Epidemiology and clinical characteristics of Morganella morganii infections: a multicenter retrospective study. J Infect Public Health 17:430–434. doi:10.1016/j.jiph.2023.12.01338262080 · doi ↗ · pubmed ↗
- 5Kolmogorov M, Yuan J, Lin Y, Pevzner PA. 2019. Assembly of long, error-prone reads using repeat graphs. Nat Biotechnol 37:540–546. doi:10.1038/s 41587-019-0072-830936562 · doi ↗ · pubmed ↗
- 6Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068–2069. doi:10.1093/bioinformatics/btu 15324642063 · doi ↗ · pubmed ↗
- 7Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. 2009. BLAST+: architecture and applications. BMC Bioinformatics 10:421. doi:10.1186/1471-2105-10-42120003500 PMC 2803857 · doi ↗ · pubmed ↗
- 8Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, Philippon A, Allesoe RL, Rebelo AR, Florensa AF, et al.. 2020. Res Finder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother 75:3491–3500. doi:10.1093/jac/dkaa 34532780112 PMC 7662176 · doi ↗ · pubmed ↗
